Capstone Investment Advisors
ZURAW

Capstone Investment Advisors’s Zura Bio Limited Warrants ZURAW Stock Holding History

Capstone Investment Advisors’s Portfolio ZURAW Stock Details ZURAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,400
Closed -$3K – 1819
2022
Q2 		$3K Sell
14,400
-35,600
-71% -$9.65K ﹤0.01% 1746
2022
Q1 		$21K Buy
+50,000
New +$20.8K ﹤0.01% 1935

Other funds holding ZURAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return

Capstone Investment Advisors's ZURAW Position: Q3 2022 in Review

Capstone Investment Advisors sold out of Zura Bio Limited Warrants (ZURAW) in Q3 2022, closing a stake of 14,400 shares — an estimated $3K sold.

Capstone Investment Advisors first reported a position in ZURAW in Q1 2022 and held it in 2 quarters. The position peaked at $21K in Q1 2022. 25 funds tracked by Wall St. Rank hold ZURAW as of Q3 2022.

  • Capstone Investment Advisors reported no remaining Zura Bio Limited Warrants position as of Q3 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 14,400 Zura Bio Limited Warrants shares in Q3 2022, an estimated $3K.
  • Capstone Investment Advisors first reported a position in Zura Bio Limited Warrants in Q1 2022 and held it in 2 quarters.
  • Capstone Investment Advisors's Zura Bio Limited Warrants position peaked at $21K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q3 2022.

Based on Capstone Investment Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.